AnaptysBio Inc. (ANAB)
NASDAQ · Healthcare
AnaptysBio Inc. Shareholder Equity 2015–2025
AnaptysBio Inc. annual shareholder equity history from 2016 to 2025. Shareholder equity represents the net worth of a company, calculated as total assets minus total liabilities.
- AnaptysBio Inc. shareholder equity as of December 31, 2025: 37.2M, a 47.49% decrease year-over-year.
- AnaptysBio Inc. shareholder equity for 2025 were 37.2M, a 47.49% decrease from 2024.
- AnaptysBio Inc. shareholder equity for 2024 were 70.9M, a 19.56% decrease from 2023.
- AnaptysBio Inc. shareholder equity for 2023 were 88.1M, a 66.39% decrease from 2022.
- AnaptysBio Inc. shareholder equity for 2022 were 262.1M.
Shareholder Equity
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| AnaptysBio Inc. Annual Shareholder Equity (Millions of US $) | |
|---|---|
| 2025 | $37 |
| 2024 | $71 |
| 2023 | $88 |
| 2022 | $262 |
| 2021 | $356 |
| 2020 | $397 |
| 2019 | $405 |
| 2018 | $486 |
| 2017 | $308 |
| 2016 | $-38 |
AnaptysBio Inc. Shareholder Equity — FAQ
AnaptysBio Inc. (ANAB) shareholder equity over the last 11 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see ANAB's shareholder equity history?
The chart and table above show AnaptysBio Inc.'s shareholder equity by year and by quarter, including the growth rate.